Patents by Inventor Patrick Page

Patrick Page has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 10772891
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: September 15, 2020
    Assignee: GENKYOTEX SUISSE SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20180235976
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: April 23, 2018
    Publication date: August 23, 2018
    Inventors: PATRICK PAGE, MIKE ORCHARD, BENOIT LALEU, FRANCESCA GAGGINI
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 9974791
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: May 22, 2018
    Assignee: GENKYOTEX SUISSE SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyrazoline dione derivatives as NADPH oxidase inhibitors
    Patent number: 9394306
    Abstract: The present invention is related to pyrazoline dione derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 27, 2010
    Date of Patent: July 19, 2016
    Assignee: GENKYOTEX SA
    Inventors: Patrick Page, Francesca Gaggini, Benoît Laleu
  • PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20150290208
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: June 25, 2015
    Publication date: October 15, 2015
    Inventors: PATRICK PAGE, MIKE ORCHARD, BENOIT LALEU, FRANCESCA GAGGINI
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 9096588
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: August 4, 2015
    Assignee: GENKYOTEX SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 9073919
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: July 7, 2015
    Assignee: GENKYOTEX SA
    Inventors: Patrick Page, Mike Orchard, Laetitia Fioraso-Cartier, Bianca Mottironi
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 9012449
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: April 21, 2015
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 9006238
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: April 14, 2015
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 8940760
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: July 5, 2013
    Date of Patent: January 27, 2015
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • NADPH OXIDASE 4 INHIBITORS AND USE THEREOF
    Publication number: 20140323500
    Abstract: The present invention is related to Nox4 inhibitors, pharmaceutical composition thereof and to their use for the treatment and/or prevention of osteoporosis or an osteoclastogenesis dysfunction, in particular osteoporotic and pre-osteoporotic osteoclastogenesis dysfunction.
    Type: Application
    Filed: November 9, 2012
    Publication date: October 30, 2014
    Inventors: Ralf Brandes, Katrin Schröder, Patrick Page, Benoît Laleu, Francesca Gaggini
  • Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
    Patent number: 8865758
    Abstract: The present invention is related to pyrazolo piperidine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: October 21, 2014
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Benoît Laleu, Francesca Gaggini, Mike Orchard
  • 2,3-disubstituted pyrazinesulfonamides as CRTH2 inhibitors
    Patent number: 8796280
    Abstract: The present invention is related to the use of 2,3 substituted pyrazine sulfonamides of formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of 2,3 substituted pyrazine sulfonamides for the modulation, notably the inhibition, of CRTH2 activity.
    Type: Grant
    Filed: April 20, 2006
    Date of Patent: August 5, 2014
    Assignee: Merck Serono, S.A.
    Inventors: Patrick Page, Matthias Schwarz, Eric Sebille, Christophe Cleva, Cedric Merlot, Maurizio Maio
  • Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
    Patent number: 8748456
    Abstract: The present invention is related to pyrazolo piperidine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: June 10, 2014
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Benoît Laleu, Francesca Gaggini, Mike Orchard
  • PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
    Publication number: 20130296362
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Application
    Filed: July 5, 2013
    Publication date: November 7, 2013
    Inventors: PATRICK PAGE, MIKE ORCHARD, BENOIT LALEU, FRANCESCA GAGGINI
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 8481562
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: July 9, 2013
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 8455486
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: June 4, 2013
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: 8455485
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: June 4, 2013
    Assignee: Genkyotex SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini
  • Piperazine-2-carboxamide derivatives
    Patent number: 8404690
    Abstract: The present invention is related to piperazine-2-carboxamide derivatives of formula (I) for the treatment and/or prophylaxis of preterm labor, premature birth, dysmenorrhea and for stopping labor prior to cesarean delivery. Wherein A, X, Y, R1 and R2 are as defined in the description.
    Type: Grant
    Filed: February 6, 2004
    Date of Patent: March 26, 2013
    Assignee: Merck Serono SA
    Inventors: Patrick Page, Catherine Jorand-Lebrun, Russell J. Thomas, Matthias Schwarz
  • Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
    Patent number: RE50878
    Abstract: The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).
    Type: Grant
    Filed: April 6, 2023
    Date of Patent: May 5, 2026
    Assignee: CALLIDITAS THERAPEUTICS SUISSE SA
    Inventors: Patrick Page, Mike Orchard, Benoit Laleu, Francesca Gaggini